Skip to main navigation Skip to search Skip to main content

Development of Safe, Non-addictive Pain Medications

Grants and Contracts Details

Description

Statement of Work KOR ligands will be targeted iteratively that include the following parameters: (a) ligands with nanomolar activity and high efficacy at the KOR; (b) improved water solubility and predicted pharmacokinetic (PK) properties; (c) effectiveness in preclinical models of immune-driven demyelination; and (d) effectiveness in preclinical models of non-immune driven demyelination.
StatusActive
Effective start/end date11/1/233/30/26

Funding

  • Research Trust of Victoria University of Wellington: $151,167.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.